title: Production of the alpha subunit of guanine nucleotide-binding protein GO by neuroendocrine tumors.
abstract: We have found that neuroendocrine tumors (including neuroblastoma, ganglioneuroma, gut carcinoid, pheochromocytoma, medullary thyroid carcinoma, insulinoma, glucagonoma, prolactinoma, carotid body tumor, and small cell lung carcinoma) produce considerable amounts (about 1000-80,000 ng/g tissue) of the alpha subunit of guanine nucleotide-binding protein, GO (GO alpha), whereas nonneuroendocrine tumors contain less than 300 ng of GO alpha/g tissue. GO alpha in the neuroendocrine tumors was present both in the soluble fraction, and cholate-extractable membrane-bound fraction of tissues. Immunoblots of membrane fractions of neuroblastoma and carcinoid tissues confirmed that the immunoreactive substance in the tumor tissues was GO alpha. Immunohistochemically, GO alpha was localized consistently in the cell membrane and occasionally in the cytoplasm of neuroendocrine tumors. GO alpha was also detected in sera of 73% patients with neuroblastoma at diagnosis, whereas serum GO alpha concentrations in control children, or patients with nonneuroendocrine tumors were lower than the detection limit of the immunoassay method employed. Serum GO alpha concentrations in patients with neuroblastoma changed with the clinical course; they fell in patients responding to treatment and increased in patients who relapsed. Since GO alpha, a specific protein in the neural and neuroendocrine cells, was found to be produced in considerable amounts by all types of neuroendocrine tumors but not in nonneuroendocrine tumors, GO alpha might be a useful biomarker for neuroendocrine tumors.
authors.affiliation: Department of Biochemistry, Aichi Prefectural Colony, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: T
authors.initials: T
authors.lastname: Asano
authors.forename: N
authors.initials: N
authors.lastname: Kamiya
authors.forename: H
authors.initials: H
authors.lastname: Haimoto
authors.forename: S
authors.initials: S
authors.lastname: Hosoda
authors.forename: A
authors.initials: A
authors.lastname: Nagasaka
authors.forename: Y
authors.initials: Y
authors.lastname: Ariyoshi
authors.forename: Y
authors.initials: Y
authors.lastname: Ishiguro
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000032:analysis; D002276:Carcinoid Tumor / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000032:analysis; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis; D004702:Endocrine Glands / Q000032:analysis; D019204:GTP-Binding Proteins / Q000032:analysis* / Q000276:immunology; D006651:Histocytochemistry; D006801:Humans; D008175:Lung Neoplasms / Q000032:analysis; D009369:Neoplasms / Q000032:analysis*; D009447:Neuroblastoma / Q000032:analysis; D009490:Neurosecretory Systems; D010673:Pheochromocytoma / Q000032:analysis; D010751:Phosphopyruvate Hydratase / Q000032:analysis
chemical_list: D053379:Chromogranin A; D002864:Chromogranins; D019204:GTP-Binding Proteins; D010751:Phosphopyruvate Hydratase